← FDA Warning Letters

Pharmathen International S.A.

FDA Warning Letter · 2026-06-16 · Center for Drug Evaluation and Research (CDER)

Letter

Company
Pharmathen International S.A.
Posted Date
2026-06-16
Letter Issue Date
2026-05-27
Issuing Office
Center for Drug Evaluation and Research (CDER)

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown